Benitec Biopharma Ltd ADR
(BNTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,565 | 10,551 | 16,547 | 4,076 | 8,630 |
| Receivables | 56 | 68 | 3 | 3 | 5 |
| Other current assets | 774 | 356 | 531 | 741 | 206 |
| TOTAL | $7,395 | $10,975 | $17,081 | $4,820 | $8,841 |
| Non-Current Assets | |||||
| PPE Net | 106 | 139 | 179 | 222 | 214 |
| Investments And Advances | 25 | 25 | 25 | 25 | 25 |
| Other Non-Current Assets | 694 | 766 | 830 | 906 | 984 |
| TOTAL | $825 | $930 | $1,034 | $1,153 | $1,223 |
| Total Assets | $8,220 | $11,905 | $18,115 | $5,973 | $10,064 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,455 | 1,830 | 2,368 | 1,880 | 1,320 |
| TOTAL | $3,153 | $2,489 | $3,011 | $2,532 | $1,909 |
| Non-Current Liabilities | |||||
| TOTAL | $354 | $422 | $491 | $559 | $635 |
| Total Liabilities | $3,507 | $2,911 | $3,502 | $3,091 | $2,544 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,645 | 1,645 | 8 | 480 | 2 |
| Common Shares | 3 | 3 | 3 | N/A | 1 |
| Retained earnings | -163,228 | -158,831 | -153,420 | -148,327 | -143,260 |
| Other shareholders' equity | -853 | -898 | -738 | -1,245 | -1,506 |
| TOTAL | $4,713 | $8,994 | $14,613 | $2,882 | $7,520 |
| Total Liabilities And Equity | $8,220 | $11,905 | $18,115 | $5,973 | $10,064 |